DaVita HealthCare Partners Inc. (NYSE:DVA) – Equities research analysts at SunTrust Banks issued their Q1 2019 earnings per share (EPS) estimates for DaVita HealthCare Partners in a report released on Thursday. SunTrust Banks analyst D. Macdonald forecasts that the company will post earnings of $0.92 per share for the quarter. SunTrust Banks also issued estimates for DaVita HealthCare Partners’ Q2 2019 earnings at $1.08 EPS.

DaVita HealthCare Partners (NYSE:DVA) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The company had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.82 billion. During the same quarter in the prior year, the business posted $1.01 earnings per share. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year.

COPYRIGHT VIOLATION WARNING: “DaVita HealthCare Partners Inc. to Post Q1 2019 Earnings of $0.92 Per Share, SunTrust Banks Forecasts (DVA)” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/09/18/davita-healthcare-partners-inc-to-post-q1-2019-earnings-of-0-92-per-share-suntrust-banks-forecasts-dva.html.

A number of other equities research analysts have also recently weighed in on the company. Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and set a $62.00 price target on shares of DaVita HealthCare Partners in a report on Thursday, May 25th. Zacks Investment Research cut DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Jefferies Group LLC cut DaVita HealthCare Partners from a “buy” rating to a “hold” rating and raised their price target for the company from $64.89 to $70.00 in a report on Monday, June 26th. BidaskClub cut DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $64.00 price target on shares of DaVita HealthCare Partners in a report on Wednesday, September 6th. Two analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $68.88.

DaVita HealthCare Partners (NYSE DVA) opened at 59.63 on Monday. DaVita HealthCare Partners has a 1-year low of $54.50 and a 1-year high of $70.16. The stock has a 50 day moving average price of $58.23 and a 200 day moving average price of $64.33. The company has a market cap of $11.40 billion, a PE ratio of 9.08 and a beta of 0.91.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. SRS Capital Advisors Inc. increased its stake in shares of DaVita HealthCare Partners by 6.6% in the 1st quarter. SRS Capital Advisors Inc. now owns 1,966 shares of the company’s stock valued at $133,000 after buying an additional 122 shares during the period. Pzena Investment Management LLC increased its stake in shares of DaVita HealthCare Partners by 2.1% in the 2nd quarter. Pzena Investment Management LLC now owns 3,398 shares of the company’s stock valued at $220,000 after buying an additional 71 shares during the period. Pacer Advisors Inc. increased its stake in shares of DaVita HealthCare Partners by 3.0% in the 1st quarter. Pacer Advisors Inc. now owns 3,422 shares of the company’s stock valued at $233,000 after buying an additional 101 shares during the period. LMR Partners LLP acquired a new stake in shares of DaVita HealthCare Partners in the 1st quarter valued at $242,000. Finally, Elk Creek Partners LLC increased its stake in shares of DaVita HealthCare Partners by 13.5% in the 1st quarter. Elk Creek Partners LLC now owns 3,885 shares of the company’s stock valued at $264,000 after buying an additional 463 shares during the period. 83.31% of the stock is owned by institutional investors.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Earnings History and Estimates for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Stock Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related stocks with our FREE daily email newsletter.